Therefore, the capability of 2LC1-1; -6; -8, the SNA-MYC (10 CH) and the SNA-MYC (18 CH) to possibly revert such M2c subtype to the more anti-tumor M1 one was appraised. This evidence concerns the gene MYC and neoplasm.